# Ligation Devices Market

> Ligation Devices Market Research Report: Size, Share, Trend Analysis By Product (Handheld Instruments and Accessories), By Procedure (Minimally Invasive Surgery and Open Surgery), and By Applications (Gastrointestinal and Abdominal Applications, Cardiovascular Applications, Gynecological Applications, Urological Applications, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.53%
- **2024:** $ 0.44 Billion
- **2025:** $ 0.46 Billion
- **2035:** $ 0.72 Billion
- **Key Players:** (US), Boston Scientific (US), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Teleflex (US), Conmed Corporation (US), Olympus Corporation (JP)

**Report ID:** MRFR/HC/6324-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

---

## Market Summary

## **Global Ligation Devices Market Overview**

Ligation Devices Market Size was valued at USD 0.42 Billion in 2023. The Ligation Devices market industry is projected to grow from USD 0.44 Billion in 2024 to USD 0.63 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.53% during the forecast period (2024 - 2032). Increasing public concern over angiodysplasia, protuberant gastrointestinal lesions, stomach variceal ulcers, and increased R&D spending on healthcare are the key market drivers contributing to market growth and expansion. 

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

## **Ligation Devices Market Trends**

The rising R&D spending on healthcare drives the Market CAGR for Ligation Devices. The growth in diseases and other disorders that need ligation devices as individuals age boosts the market. In the next years, the industry would also profit from a rise in healthcare spending, which could be used to treat several cardiovascular problems along with various other illnesses. Yet, the increased cost of ligation devices employed in surgical procedures may hamper industry growth. Conversely, the increasing acceptance of minimally invasive procedures utilizing ligation devices & accessories is expected to give attractive opportunities for market expansion in the future generations.

The public's increased worry over angiodysplasia, protuberant intestinal spots, and stomach variceal will motivate the industry to create larger revenues throughout the forecast. The advancement of less invasive treatments using ligation accessories will drive market demand in the next years. The rising prevalence of illnesses and other disorders places a significant demand on ligation devices. Furthermore, increased expenditure on medical care for therapies such as cardiovascular illnesses would drive the industry toward substantial development potential. Another reason for boosting the sector is the growth in diseases and other disorders that require ligation devices as individuals age.

In the next years, the industry would also profit from a rise in healthcare spending, which could be used to treat several cardiovascular problems and various other illnesses.

The World Health Organization designated COVID-19 as a health emergency of worldwide significance. Ligation devices may be employed to aid in a variety of surgical operations. Yet, manpower shortages and resource constraints caused by COVID-19 will likely have a detrimental influence on industry growth throughout the projection period. Furthermore, the vulnerability of patients having surgery to COVID-19 exposure would impede the development of the ligation devices demanded for the first time. The emergence of tight government rules surrounding lockdowns hampered industry expansion in the first era.

For instance, according to a 2017 survey done by the European Heart Network, cardiovascular illnesses are responsible for 3.9 million fatalities in Europe. As the prevalence of disorders requiring minimally invasive surgery rises, so will the use of ligation devices. Additionally, favorable pay policies, rising medical costs, and rising scientific and technological expenditures contribute to market expansion. Thus, it is anticipated that demand for Ligation Devices will increase throughout the projected timeframe due to the rising R&D spending on healthcare. Thus, driving the Ligation Devices market revenue.

## **Ligation Devices Market Segment Insights**

### **Ligation Devices Product Insights**

The  Ligation Devices market segmentation, based on Product, includes Handheld Instruments and Accessories. The accessories segment dominated the market, accounting for 68% of market revenue (USD 0.3 Billion) in 2022 because of the rising number of surgical operations, particularly in emerging markets. This increase might be attributed to an increase in the number of surgical operations, particularly in developing countries. In addition, because of being accessible in numerous sizes and diverse uses in surgical procedures, this category is predicted to grow.

### **Ligation Devices Procedure Insights**

The  Ligation Devices market segmentation, based on Procedures, includes [Minimally Invasive Surgery](../../../reports/minimally-invasive-surgery-devices-market-7875) and Open Surgery. The open surgery category generated the highest market revenue of about 57% (USD 0.2 billion) in 2022. It is also predicted to expand fast, owing to an increase in the rates of cardiac illnesses and open-heart surgical operations. Various forms of open-heart operations, including replacements for mitral valves needing ligation devices, are also propelling the market.

**Figure 1:  Ligation Devices Market, by Procedure, 2022 & 2032 (USD Billion)**

****

**_Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review_**

### **Ligation Devices Application Insights**

The  Ligation Devices market segmentation, based on Application, includes Gastrointestinal and Abdominal Applications, Cardiovascular Applications, Gynecological Applications, Urological Applications, and Others. The gastrointestinal and abdominal applications segment dominated the market, accounting for 39% of market revenue (USD 0.2 Billion) in 2022. This is attributed to an increase in the incidence of heart disorders. Furthermore, the demand for ligation devices is projected to grow as innovation progresses in cardiac robotic surgery.

### **Ligation Devices Regional Insights**

By region, the research provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Ligation Devices market area will dominate this market during the projected timeframe; because of growing healthcare expenditures and the incidence of chronic illnesses, as well as rising government spending and substantial rivals, the industry is expanding, which will boost the market growth in the North American region.

Further, the major countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2:  Ligation Devices Market Share by Region 2022 (USD Billion)**

****

**_Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review_**

Europe region’s Ligation Devices market accounts for the second-highest market share due to the Massive patient population and fast infrastructure expansion. Further, the German Ligation Devices market holds the largest market share, and the UK Ligation Devices market is expected to grow and expand significantly in the European region during the projected timeframe.

The Asia-Pacific Ligation Devices Market is expected to grow quickly during the projected timeframe. This is due to rapid expansion largely due to increased [gastrointestinal](../../../reports/gastrointestinal-drugs-market-558) illnesses, which may be addressed using minimally invasive procedures utilizing ligation devices. Moreover, China’s Ligation Devices market dominates the market share, and the Indian Ligation Devices market is expected to expand and grow steadily in the Asia-Pacific region during the projected timeframe.

**Ligation Devices Key Market Players & Competitive Insights**

Leading market players invested heavily in research and Development (R&D) to scale up their manufacturing units and develop technologically advanced solutions, which will help the Ligation Devices market grow worldwide. Market participants are also undertaking various organic or inorganic strategic approaches to strengthen and expand their  footprint, with significant market developments including new product portfolios, contractual deals, mergers and acquisitions, capital expenditure, higher investments, and strategic alliances with other organizations. Businesses are also coming up with marketing strategies such as digital marketing, social media influencing, and content marketing to increase their scope of profit earnings.

The Ligation Devices industry must offer cost-effective and sustainable options to survive in a highly fragmented and dynamic market climate.

Manufacturing locally to minimize operational expenses and offer aftermarket services to customers is one of the critical business strategies organizations use in the  Ligation Devices industry to benefit customers and capture untapped market share and revenue. The Ligation Devices industry has recently offered significant advantages to the healthcare industry. Moreover, more industry participants are utilizing and adopting cutting-edge Technology has grown substantially.

Major players in the Ligation Devices market, including Medtronic, Johnson & Johnson, The Cooper Companies Inc., Conmed Corporation, Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, and Genicon Inc, are attempting to expand market share and demand by investing in R&D operations to produce sustainable and affordable solutions.

CooperSurgical is a dependable source of medical supplies, gadgets, and recyclables that meet women's medical demands across their lifetimes. They are a prominent female healthcare and fertility firm committed to placing opportunity on the path of women, infants, and households in critical medical situations. They enable healthcare practitioners to give speedy results, successful therapies, and more alternatives at the appropriate moment by providing a wide variety of new medical therapies so that women, infants, and their loved ones can discover greater opportunities quicker than ever before.

CooperSurgical purchased OBP Medical Corp in May 2021, a medical device company in the United States that develops and produces distinctive goods, including single-use vaginal speculums featuring embedded LED lighting.

Genicon, Inc. designs, manufactures and distributes surgical gear for laparoscopic surgery. Laparoscopic equipment that includes without blade products, protected and pyramid tip structures, and disposable suction systems for irrigation are available from the company. Genicon, Inc. signed a distribution agreement with Greenpine Pharma, China, in September 2019 to distribute its entire product portfolio in China.

**Key Companies in the Ligation Devices market include**

### Ligation Devices Market Industry Developments

- **Q2 2024: Ethicon Launches Next-Generation Endoscopic Ligation Device** Ethicon, a Johnson & Johnson MedTech company, announced the commercial launch of its new endoscopic ligation device designed for minimally invasive gastrointestinal procedures, expanding its surgical solutions portfolio.
- **Q2 2024: Olympus Receives FDA Clearance for New Ligation Device for GI Endoscopy** Olympus Corporation announced it has received FDA 510(k) clearance for its latest ligation device, enabling broader use in endoscopic variceal ligation procedures in the United States.
- **Q3 2024: Teleflex Announces European Launch of Advanced Ligation Clip Applier** Teleflex launched its new ligation clip applier in select European markets, aiming to improve procedural efficiency and patient outcomes in laparoscopic surgeries.
- **Q3 2024: ConMed Expands Manufacturing Facility to Increase Ligation Device Production** ConMed Corporation completed an expansion of its manufacturing facility in the United States to meet growing demand for its ligation devices used in minimally invasive surgeries.
- **Q4 2024: Applied Medical Launches New Ligation System for Laparoscopic Procedures** Applied Medical announced the launch of a new ligation system designed to enhance safety and efficiency in laparoscopic surgeries, now available in North America and Europe.
- **Q4 2024: CooperSurgical Acquires Ligation Device Technology from MedTech Startup** CooperSurgical announced the acquisition of proprietary ligation device technology from a medical technology startup, aiming to strengthen its surgical product portfolio.
- **Q1 2025: FDA Approves Medtronic’s Novel Ligation Device for Urological Surgeries** The U.S. Food and Drug Administration approved Medtronic’s new ligation device for use in urological surgeries, marking a significant regulatory milestone for the company.
- **Q1 2025: Olympus Appoints New Head of Surgical Devices Division** Olympus Corporation announced the appointment of a new executive to lead its Surgical Devices Division, which includes the company’s ligation device business.
- **Q2 2025: Teleflex Secures Major Supply Contract for Ligation Devices with NHS England** Teleflex announced it has secured a multi-year supply contract to provide ligation devices to NHS England, expanding its presence in the UK healthcare market.
- **Q2 2025: ConMed Launches Next-Generation Ligation Clip for Minimally Invasive Surgery** ConMed introduced a next-generation ligation clip designed to improve ease of use and reliability in minimally invasive surgical procedures.
- **Q2 2025: Olympus Opens New R&D Center Focused on Ligation Device Innovation** Olympus opened a new research and development center in Japan dedicated to advancing ligation device technology for endoscopic and laparoscopic procedures.
- **Q3 2025: Ethicon Partners with Leading Hospital Network for Ligation Device Clinical Trials** Ethicon announced a partnership with a major hospital network to conduct clinical trials evaluating the safety and efficacy of its latest ligation device in real-world surgical settings.

## **Ligation Devices Market Segmentation**

### **Ligation Devices Product Outlook**

### **Ligation Devices Procedure Outlook**

### **Ligation Devices Application Outlook**

### **Ligation Devices Regional Outlook**

## Market Drivers

### Surge in Surgical Procedures

The rise in the number of surgical procedures performed worldwide is significantly influencing the Ligation Devices Market. As surgical techniques evolve, the demand for ligation devices is expected to increase. Data indicates that the number of surgeries, particularly minimally invasive procedures, has been on the rise, which correlates with the growing adoption of ligation devices. This trend is likely to continue as healthcare systems strive to improve patient outcomes and reduce recovery times. The increasing volume of surgeries necessitates the availability of effective ligation solutions, thereby creating a robust market for ligation devices. Additionally, the expansion of surgical facilities and advancements in surgical training may further contribute to this growth.

### Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases such as cancer, cardiovascular disorders, and gastrointestinal conditions is a primary driver of the Ligation Devices Market. As these diseases often require surgical interventions, the demand for ligation devices is expected to rise. According to recent statistics, the prevalence of chronic diseases is projected to increase, leading to a higher number of surgical procedures. This trend suggests that healthcare providers will increasingly rely on ligation devices to manage these conditions effectively. The growing patient population necessitates innovative solutions, thereby propelling the ligation devices market forward. Furthermore, advancements in ligation technology may enhance surgical outcomes, further driving market growth.

### Growing Awareness and Training Programs

The increasing awareness of ligation techniques and the establishment of training programs for healthcare professionals are driving the Ligation Devices Market. As more surgeons become proficient in using ligation devices, the adoption rate is expected to rise. Educational initiatives and workshops aimed at enhancing surgical skills are being implemented in various regions, which may lead to a more skilled workforce. This trend suggests that as healthcare professionals become more knowledgeable about the benefits and applications of ligation devices, the market will likely experience growth. Additionally, partnerships between [medical device](https://www.marketresearchfuture.com/reports/medical-devices-market-2869) manufacturers and educational institutions may further enhance the reach and effectiveness of these training programs.

### Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are crucial drivers of the Ligation Devices Market. Governments and health authorities are increasingly recognizing the importance of ligation devices in surgical procedures, leading to streamlined approval processes. This regulatory support encourages manufacturers to innovate and bring new products to market. Furthermore, favorable reimbursement policies for ligation procedures can enhance the accessibility of these devices, making them more appealing to healthcare providers. As reimbursement rates improve, hospitals and clinics are more likely to invest in ligation devices, thereby stimulating market growth. This trend indicates a positive outlook for the ligation devices market as it aligns with broader healthcare objectives.

### Technological Innovations in Ligation Devices

Technological advancements in ligation devices are transforming the Ligation Devices Market. Innovations such as the development of advanced materials, improved design, and enhanced functionality are making ligation devices more effective and user-friendly. These innovations not only improve surgical outcomes but also increase the efficiency of procedures. The introduction of smart ligation devices, which may incorporate features like real-time feedback and enhanced visualization, is expected to attract more healthcare providers. As a result, the market is likely to witness a surge in demand for these technologically advanced devices. Furthermore, ongoing research and development efforts are anticipated to yield new products that could further expand the market.

## Future Outlook

The Ligation Devices Market is projected to grow at a 4.53% CAGR from 2025 to 2035, driven by technological advancements, increasing surgical procedures, and rising healthcare expenditures.

**New opportunities:**

- Expansion into emerging markets with tailored ligation solutions. Development of biodegradable ligation devices for eco-friendly practices. Integration of AI in ligation device design for enhanced precision.

By 2035, the Ligation Devices Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Handheld Instruments (Largest) vs. Accessories (Fastest-Growing)

The ligation devices market is primarily dominated by handheld instruments, which hold the largest share due to their versatility and ease of use in various surgical procedures. These instruments have become essential in the operating room, enabling surgeons to perform complex ligation tasks efficiently. Accessories, while smaller in market share, are emerging as a significant part of the market, driven by the increasing demand for better surgical outcomes and innovations that enhance procedure efficiency, supporting ligation devices market growth.

Market Dynamics: Handheld Instruments (Dominant) vs. Accessories (Emerging)

Handheld instruments represent the dominant force in the ligation devices market, offering unparalleled reliability and efficiency in surgical applications. Comprising staple devices and other specialized tools, they are integral to performing ligations effectively. On the other hand, accessories such as clips and specialized ligation devices are quickly establishing themselves as an emerging segment in the market. Their rapid growth can be attributed to advancements in material technology and an increasing focus on enhancing surgical outcomes. The complementary nature of these accessories to handheld instruments allows for more precise surgical interventions, indicating a trend towards combined usage in operating rooms.

### By Procedure: Minimally Invasive Surgery (Largest) vs. Open Surgery (Fastest-Growing)

In the ligation devices market, the distribution of market share highlights that minimally invasive surgery (MIS) is the largest segment, due to its increasing acceptance among healthcare professionals and patients alike. The preference for MIS is driven by its advantages, including reduced recovery times and lower complication rates, making it a preferred option in numerous surgical applications. Conversely, open surgery still holds a significant position, particularly in complex procedures where visualization and access are critical.

Surgical Approach: Minimally Invasive Surgery (Dominant) vs. Open Surgery (Emerging)

Minimally Invasive Surgery (MIS) has emerged as the dominant force within the ligation devices segment, providing enhanced patient outcomes and fostering growth through technological advancements such as robotic-assisted techniques and improved instrument designs. The rising trend of outpatient procedures further solidifies its market position. On the other hand, open surgery, while traditionally established, represents the emerging segment, particularly as healthcare providers integrate innovative ligation techniques to address specific surgical challenges. Its adaptability in complex cases and ability to complement MIS practices showcases the continued relevance of open surgery within this evolving market.

### By Application: Gastrointestinal and Abdominal Applications (Largest) vs. Cardiovascular Applications (Fastest-Growing)

In the Ligation Devices Market, the distribution of market share among key applications reveals that Gastrointestinal and Abdominal Applications hold the largest slice, capitalizing on increasing surgical procedures in this area. Healthcare providers favor ligation devices for procedures such as appendectomies and resections, contributing significantly to this segment's dominance. In contrast, despite holding a smaller market share, Cardiovascular Applications are rapidly gaining traction as technological advancements improve efficacy and safety in vascular surgeries, attracting investments and driving market growth in this area.

Gastrointestinal Applications: Dominant vs. Cardiovascular Applications: Emerging

The Gastrointestinal Applications segment is characterized by high demand for ligation devices due to a rise in gastrointestinal surgeries necessitated by lifestyle diseases and an aging population. This dominance stems from the segment's established protocols and continued innovation in device design. Meanwhile, the Cardiovascular Applications segment is emerging rapidly, driven by advancements in minimally invasive surgery and growing incidence of cardiovascular diseases. Leaders in this space are focusing on expanding their product offerings to include state-of-the-art ligation devices that enhance surgical outcomes, making this segment increasingly appealing to healthcare institutions.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for ligation devices, holding approximately 45% of the global market share within the ligation devices market. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and a strong focus on minimally invasive surgical techniques. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies in the market. The United States is the leading country in this region, with major players such as Medtronic, Boston Scientific, and Johnson & Johnson dominating the landscape. The competitive environment is characterized by continuous product development and strategic partnerships. The presence of well-established healthcare facilities and a high rate of surgical procedures contribute to the robust demand for ligation devices.

### Europe : Emerging Market with Growth Potential

Europe is the second-largest market for ligation devices, accounting for approximately 30% of the global market share. The region is experiencing growth due to an aging population, increasing surgical procedures, and rising healthcare expenditures. Regulatory frameworks, such as the Medical Device Regulation (MDR), are enhancing product safety and efficacy, thereby boosting market confidence and adoption rates. Germany and France are the leading countries in this market, with significant contributions from companies like B. Braun Melsungen AG and Olympus Corporation. The competitive landscape is marked by innovation and collaboration among key players, focusing on developing advanced ligation solutions. The presence of a well-established healthcare system and increasing awareness of minimally invasive procedures further drive market growth.

### Asia-Pacific : Rapidly Growing Market Segment

Asia-Pacific is witnessing rapid growth in the ligation devices market, holding about 20% of the global market share. The region's expansion is fueled by increasing healthcare investments, a rising number of surgical procedures, and a growing awareness of advanced medical technologies. Countries like China and India are focusing on improving healthcare infrastructure, which is expected to further drive demand for ligation devices in the coming years. China is the largest market in this region, with significant contributions from local and international players. The competitive landscape is evolving, with companies like Cook Medical and Teleflex expanding their presence. The increasing prevalence of chronic diseases and the push for minimally invasive surgeries are key factors propelling market growth in Asia-Pacific, making it a focal point for future investments.

### Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region is gradually emerging in the ligation devices market, holding around 5% of the global market share. Growth is driven by increasing healthcare investments, a rising prevalence of chronic diseases, and a growing number of surgical procedures. However, regulatory challenges and varying healthcare standards across countries pose significant hurdles to market expansion. Countries like South Africa and the UAE are leading the market in this region, with a growing presence of international players. The competitive landscape is characterized by a mix of local and global companies striving to meet the increasing demand for ligation devices. Efforts to improve healthcare infrastructure and regulatory frameworks are expected to enhance market growth in the coming years.

## Competitive Benchmarking

The Ligation Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive surgical procedures. Key players such as Medtronic (US), Boston Scientific (US), and Johnson & Johnson (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through the development of advanced ligation devices that integrate digital health technologies, while Boston Scientific (US) emphasizes strategic partnerships to expand its product offerings and market reach. Johnson & Johnson (US) is leveraging its extensive research capabilities to introduce novel ligation solutions, thereby reinforcing its competitive positioning in the market. The competitive structure of the Ligation Devices Market appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing to optimize supply chains and reduce operational costs. This tactic not only enhances efficiency but also allows for quicker responses to regional market demands. The collective influence of these key players shapes a competitive environment where innovation and operational excellence are paramount. In August 2025, Medtronic (US) announced the launch of its latest ligation device, which incorporates AI-driven analytics to assist surgeons in real-time decision-making during procedures. This strategic move is likely to enhance surgical outcomes and position Medtronic as a leader in the integration of technology within surgical devices. The introduction of such advanced solutions may set new benchmarks for performance and reliability in the market. In September 2025, Boston Scientific (US) entered into a collaboration with a leading healthcare technology firm to develop a next-generation ligation device that utilizes smart technology for enhanced patient monitoring. This partnership underscores Boston Scientific's commitment to innovation and reflects a broader trend towards integrating digital health solutions into surgical devices. Such collaborations may not only expand their product portfolio but also improve patient outcomes through enhanced monitoring capabilities. In July 2025, Johnson & Johnson (US) completed the acquisition of a smaller firm specializing in biodegradable ligation devices. This acquisition is indicative of Johnson & Johnson's strategy to diversify its product offerings and tap into the growing demand for sustainable medical solutions. By integrating biodegradable materials into their ligation devices, the company positions itself favorably in a market increasingly focused on sustainability and environmental impact. As of October 2025, the Ligation Devices Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming increasingly vital, as companies seek to leverage complementary strengths to enhance their competitive edge. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, suggesting that future differentiation will hinge on the ability to deliver advanced, reliable, and sustainable solutions.

## Recent News & Developments

- **Q2 2024: Ethicon Launches Next-Generation Endoscopic Ligation Device** Ethicon, a Johnson & Johnson MedTech company, announced the commercial launch of its new endoscopic ligation device designed for minimally invasive gastrointestinal procedures, expanding its surgical solutions portfolio.
- **Q2 2024: Olympus Receives FDA Clearance for New Ligation Device for GI Endoscopy** Olympus Corporation announced it has received FDA 510(k) clearance for its latest ligation device, enabling broader use in endoscopic variceal ligation procedures in the United States.
- **Q3 2024: Teleflex Announces European Launch of Advanced Ligation Clip Applier** Teleflex launched its new ligation clip applier in select European markets, aiming to improve procedural efficiency and patient outcomes in laparoscopic surgeries.
- **Q3 2024: ConMed Expands Manufacturing Facility to Increase Ligation Device Production** ConMed Corporation completed an expansion of its manufacturing facility in the United States to meet growing demand for its ligation devices used in minimally invasive surgeries.
- **Q4 2024: Applied Medical Launches New Ligation System for Laparoscopic Procedures** Applied Medical announced the launch of a new ligation system designed to enhance safety and efficiency in laparoscopic surgeries, now available in North America and Europe.
- **Q4 2024: CooperSurgical Acquires Ligation Device Technology from MedTech Startup** CooperSurgical announced the acquisition of proprietary ligation device technology from a medical technology startup, aiming to strengthen its surgical product portfolio.
- **Q1 2025: FDA Approves Medtronic’s Novel Ligation Device for Urological Surgeries** The U.S. Food and Drug Administration approved Medtronic’s new ligation device for use in urological surgeries, marking a significant regulatory milestone for the company.
- **Q1 2025: Olympus Appoints New Head of Surgical Devices Division** Olympus Corporation announced the appointment of a new executive to lead its Surgical Devices Division, which includes the company’s ligation device business.
- **Q2 2025: Teleflex Secures Major Supply Contract for Ligation Devices Market with NHS England** Teleflex announced it has secured a multi-year supply contract to provide ligation devices to NHS England, expanding its presence in the UK healthcare market.
- **Q2 2025: ConMed Launches Next-Generation Ligation Clip for Minimally Invasive Surgery** ConMed introduced a next-generation ligation clip designed to improve ease of use and reliability in minimally invasive surgical procedures.
- **Q2 2025: Olympus Opens New R&D Center Focused on Ligation Device Innovation** Olympus opened a new research and development center in Japan dedicated to advancing ligation device technology for endoscopic and laparoscopic procedures.
- **Q3 2025: Ethicon Partners with Leading Hospital Network for Ligation Device Clinical Trials** Ethicon announced a partnership with a major hospital network to conduct clinical trials evaluating the safety and efficacy of its latest ligation device in real-world surgical settings.

## Report Scope

| MARKET SIZE 2024 | 0.44(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 0.4599(USD Billion) |
| MARKET SIZE 2035 | 0.7165(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.53% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Teleflex (US), Conmed Corporation (US), Olympus Corporation (JP) |
| Segments Covered | Product, Procedure, Applications, Region |
| Key Market Opportunities | Advancements in minimally invasive surgical techniques drive demand in the Ligation Devices Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the ligation devices market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Ligation Devices Market as of 2024?**
A: The Ligation Devices Market was valued at 0.44 USD Billion in 2024.

**Q: What is the projected market size for the Ligation Devices Market in 2035?**
A: The market is projected to reach 0.7165 USD Billion by 2035.

**Q: What is the expected CAGR for the Ligation Devices Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Ligation Devices Market during 2025 - 2035 is 4.53%.

**Q: Which companies are considered key players in the Ligation Devices Market?**
A: Key players include Medtronic, Boston Scientific, Johnson & Johnson, Stryker, and B. Braun Melsungen AG.

**Q: What are the main product segments in the Ligation Devices Market?**
A: The main product segments include Handheld Instruments and Accessories, valued at 0.4332 USD Billion and 0.2833 USD Billion respectively.

**Q: How do the application segments of the Ligation Devices Market compare?**
A: Gastrointestinal and Abdominal Applications lead with 0.25 USD Billion, followed by Cardiovascular Applications at 0.17 USD Billion.

**Q: What is the market size for minimally invasive surgery procedures in 2024?**
A: Minimally invasive surgery procedures were valued at 0.264 USD Billion in 2024.

**Q: What is the projected growth for open surgery procedures by 2035?**
A: Open surgery procedures are projected to grow to 0.2857 USD Billion by 2035.

**Q: Which application segment is expected to see the highest growth in the Ligation Devices Market?**
A: Gastrointestinal and Abdominal Applications are expected to see the highest growth, reaching 0.25 USD Billion by 2035.

**Q: How does the performance of the Accessories segment compare to Handheld Instruments?**
A: The Accessories segment is projected to reach 0.2833 USD Billion, while Handheld Instruments are expected to reach 0.4332 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/ligation-devices-market-7794*